Market revenue in 2021 | USD 1,867.3 million |
Market revenue in 2030 | USD 2,643.4 million |
Growth rate | 3.9% (CAGR from 2021 to 2030) |
Largest segment | Endoscopy |
Fastest growing segment | Blood test |
Historical data covered | 2018 - 2020 |
Base year for estimation | 2021 |
Forecast period covered | 2022 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Endoscopy, Blood test, H. pylori test, Calprotectin test, Immunoglobulin A test |
Key market players worldwide | BioMerieux SA, Roche Holding AG, Abbott Laboratories, Beckman Coulter, Diasorin SpA, Siemens Healthineers AG ADR, Qiagen NV, Meridian Bioscience, Hologic Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to gastrointestinal diagnostics market will help companies and investors design strategic landscapes.
Endoscopy was the largest segment with a revenue share of 28.75% in 2021. Horizon Databook has segmented the North America gastrointestinal diagnostics market based on endoscopy, blood test, h. pylori test, calprotectin test, immunoglobulin a test covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America gastrointestinal diagnostics market, including forecasts for subscribers. This continent databook contains high-level insights into North America gastrointestinal diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account